News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
697,356 Results
Type
Article (39618)
Company Profile (247)
Press Release (657491)
Multimedia
Podcasts (47)
Webinars (12)
Section
Business (204141)
Career Advice (2007)
Deals (35417)
Drug Delivery (95)
Drug Development (81029)
Employer Resources (172)
FDA (16168)
Job Trends (14852)
News (345131)
Policy (32524)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2553)
Accelerated approval (5)
Adcomms (20)
Allergies (82)
Alliances (49407)
ALS (86)
Alzheimer's disease (1367)
Antibody-drug conjugate (ADC) (112)
Approvals (16170)
Artificial intelligence (241)
Autoimmune disease (20)
Automation (15)
Bankruptcy (360)
Best Places to Work (11637)
BIOSECURE Act (18)
Biosimilars (104)
Biotechnology (175)
Bladder cancer (60)
Brain cancer (26)
Breast cancer (262)
Cancer (2083)
Cardiovascular disease (167)
Career advice (1674)
Career pathing (29)
CAR-T (143)
Cell therapy (403)
Cervical cancer (19)
Clinical research (65834)
Collaboration (794)
Compensation (508)
Complete response letters (19)
COVID-19 (2582)
CRISPR (37)
C-suite (223)
Cystic fibrosis (100)
Data (2051)
Decentralized trials (2)
Denatured (17)
Depression (39)
Diabetes (256)
Diagnostics (6348)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (118)
Drug pricing (96)
Drug shortages (25)
Duchenne muscular dystrophy (91)
Earnings (86338)
Editorial (35)
Employer branding (21)
Employer resources (146)
Events (111895)
Executive appointments (693)
FDA (17352)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (718)
Gene editing (100)
Generative AI (19)
Gene therapy (285)
GLP-1 (697)
Government (4405)
Grass and pollen (4)
Guidances (51)
Healthcare (18817)
Huntington's disease (23)
IgA nephropathy (24)
Immunology and inflammation (109)
Indications (26)
Infectious disease (2722)
Inflammatory bowel disease (133)
Inflation Reduction Act (8)
Influenza (50)
Intellectual property (91)
Interviews (311)
IPO (16494)
IRA (40)
Job creations (3629)
Job search strategy (1422)
Kidney cancer (9)
Labor market (36)
Layoffs (460)
Leadership (16)
Legal (7905)
Liver cancer (72)
Lung cancer (302)
Lymphoma (139)
Machine learning (5)
Management (58)
Manufacturing (282)
MASH (62)
Medical device (13346)
Medtech (13351)
Mergers & acquisitions (19438)
Metabolic disorders (655)
Multiple sclerosis (75)
NASH (16)
Neurodegenerative disease (83)
Neuropsychiatric disorders (24)
Neuroscience (1872)
NextGen: Class of 2025 (6516)
Non-profit (4476)
Northern California (2533)
Now hiring (38)
Obesity (353)
Opinion (203)
Ovarian cancer (73)
Pain (80)
Pancreatic cancer (80)
Parkinson's disease (146)
Partnered (21)
Patents (222)
Patient recruitment (99)
Peanut (46)
People (57208)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20504)
Phase II (28988)
Phase III (21606)
Pipeline (1115)
Policy (130)
Postmarket research (2563)
Preclinical (8675)
Press Release (64)
Prostate cancer (98)
Psychedelics (30)
Radiopharmaceuticals (244)
Rare diseases (371)
Real estate (5909)
Recruiting (65)
Regulatory (22202)
Reports (46)
Research institute (2321)
Resumes & cover letters (349)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (65)
Series A (124)
Series B (81)
Service/supplier (11)
Sickle cell disease (52)
Southern California (2179)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (28)
Startups (3572)
State (2)
Stomach cancer (13)
Supply chain (65)
Tariffs (24)
The Weekly (28)
United States (21997)
Vaccines (668)
Venture capitalists (38)
Weight loss (229)
Women's health (34)
Worklife (15)
Date
Last 7 days (468)
Last 30 days (2194)
Last 365 days (32795)
2025 (9203)
2024 (35219)
2023 (40076)
2022 (51174)
2021 (55711)
2020 (54085)
2019 (46545)
2018 (35026)
2017 (32110)
2016 (31481)
2015 (37556)
2014 (31324)
2013 (26351)
2012 (28575)
2011 (29263)
2010 (27330)
Location
Africa (718)
Alabama (52)
Alaska (7)
Arizona (229)
Arkansas (13)
Asia (37754)
Australia (6176)
California (5776)
Canada (1939)
China (489)
Colorado (254)
Connecticut (262)
Delaware (134)
Europe (81019)
Florida (860)
Georgia (202)
Idaho (57)
Illinois (513)
India (25)
Indiana (300)
Iowa (9)
Japan (149)
Kansas (102)
Kentucky (23)
Louisiana (9)
Maine (62)
Maryland (856)
Massachusetts (4330)
Michigan (215)
Minnesota (378)
Mississippi (2)
Missouri (78)
Montana (27)
Nebraska (25)
Nevada (60)
New Hampshire (62)
New Jersey (1659)
New Mexico (28)
New York (1650)
North Carolina (935)
North Dakota (7)
Northern California (2533)
Ohio (194)
Oklahoma (14)
Oregon (33)
Pennsylvania (1305)
Puerto Rico (11)
Rhode Island (30)
South America (1096)
South Carolina (20)
South Dakota (1)
Southern California (2179)
Tennessee (99)
Texas (860)
Utah (171)
Virginia (135)
Washington D.C. (59)
Washington State (530)
West Virginia (3)
Wisconsin (51)
697,356 Results for "lakewood amedex inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tiziana Life Sciences Announces Agreement for Product Development Services with Renaissance Lakewood, LLC
February 24, 2025
·
6 min read
Business
Lakewood-Amedex Appoints Chief Medical Officer and Adds New Management Team Members
Lakewood-Amedex Inc. announced that Sumita Paul, MD, MPH, MBA has joined Lakewood-Amedex as Chief Medical Officer and Senior Vice President, Research and Development to lead its recently recruited scientific-clinical management team.
January 19, 2022
·
4 min read
Drug Development
Lakewood-Amedex Enrolls First Patient in Phase 2 Clinical Trial for Patients with Chronic Diabetic Foot Ulcers (cDFU)
Lakewood-Amedex, Inc. announced today that it has commenced its second Phase 2 study using Bisphosphocin Nu-3 antimicrobial in treating patients with diabetic foot ulcers (DFU).
April 5, 2022
·
4 min read
Business
LAKEWOOD-AMEDEX APPOINTS TWO NEW BOARD MEMBERS
Elects Thomas Pfisterer and Douglas Manion, MD, FRCP(C), to the Board of Directors.
January 25, 2022
·
3 min read
Drug Development
Transparency Life Sciences and Lakewood Amedex Launch Protocol Design for New Clinical Trial on Chronic Diabetic Foot Ulcers
Transparency Life Sciences (TLS) today announced a partnership with the Lakewood Amedex Inc. for crowdsourced design of a Phase 2a/b protocol to test a novel class of synthetic broad-spectrum antimicrobials and antifungals for the treatment of Chronic Diabetic Foot Ulcers (cDFU).
June 3, 2020
·
3 min read
BioMidwest
Lakewood-Amedex Receives Notice of Allowance for Two U.S. Patents Covering the Broad-Spectrum Antimicrobial Nu-8 Bisphosphocin®
Lakewood-Amedex Inc. announced that the U.S. Patent and Trademark Office has issued a “Notice of Allowance” for two broad patent applications related to the Company’s broad-spectrum antimicrobial Nu-8 Bisphosphocin compound, titled “Antimicrobial Compounds, Compositions, and Uses Thereof.” The “Notice of Allowance” indicates that the USPTO is satisfied that the patent applications meet all USPTO requirements.
May 27, 2020
·
4 min read
Press Releases
KRTL Holding Group Announces KRTL Biotech Inc. Signs MOU with Industria Químico Farmacéutica Sigma Corp. S.R.L. to Pursue Strategic International Merger
March 25, 2025
·
3 min read
Press Releases
Mesa Laboratories, Inc. to Announce Third Quarter Results on February 4, 2025
January 17, 2025
·
1 min read
Drug Development
Lakewood-Amedex Prepares To Launch A Phase 2 cDFU Clinical Trial for Its Nu-3 Antimicrobial In The Bahamas
Lakewood-Amedex Inc., a leading developer of novel anti-infective pharmaceuticals, announced today it had entered into a collaboration agreement with Nassau based Foot and Ankle International (Bahamas) to conduct two Phase 2 cDFU clinical trial for its topically applied Nu-3 antimicrobial used to eliminate infection and promote wound healing in patients with chronic diabetic foot ulcers (cDFU).
January 17, 2019
·
6 min read
Press Releases
Nika Pharmaceuticals, Inc. (NIKA) Latest Developments
April 14, 2025
·
2 min read
1 of 69,736
Next
